In agreement with this, analysis of publicly available mRNA expression databases supported a general upregulation of PSPH in T-ALL samples, with an average 2.6-fold upregulation of PSPH mRNA in T-ALL patient samples versus normal bone marrow controls (Fig. 5a). This evidence concerns the gene PSPH and acute lymphoblastic leukemia.